NEW YORK, Oct. 30 - Myriad Genetics and drug giant Pharmacia have entered into a pharmacogenomics alliance that has been designed ultimately to develop and commercialize technologies to help researchers begin to apply personalized medicine, Myriad said on Tuesday.

Terms of the alliance, which is open-ended, call for Myriad, of Salt Lake City, to use its gene-sequencing technology to analyze SNPs from a variety of populations, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.